The Motley Fool

Why I’d sell multi-bagger growth stock Versarien plc today

Shareholders of materials group Versarien (LSE: VRS) have seen the value of their stock rise by 296% over the last year. However, those same shares have also lost 37% of their value since peaking in January.

Now seems like a good opportunity to take stock of the situation and I believe potential investors need to answer two questions:

5G is here – and shares of this ‘sleeping giant’ could be a great way for you to potentially profit!

According to one leading industry firm, the 5G boom could create a global industry worth US$12.3 TRILLION out of thin air…

And if you click here we’ll show you something that could be key to unlocking 5G’s full potential...

  • What’s the outlook for the business?
  • Are the shares attractively valued?

A new opportunity

The firm’s big hope for future growth lies in products which use graphene, a carbon material that could be the next wonder material.

Most potential uses for graphene are still in the development stage. A good example is the medical trial announced by Versarien today. This will see the firm work with a surgeon at Addenbrooke’s Hospital in Cambridge to test a new type of wound dressing.

The firm will develop “a range of graphene-based sensor technologies to enable the creation of digital bandages and wound dressings capable of various forms of physiological movement and excretion detection.”

From what I can tell, the goal of this is to produce dressings which enable a patient recovering at home to tell when their dressing needs changing, or if their wound is becoming infected.

The firm is also working on potential products for the chemical, aerospace and consumer goods sectors plus a potential joint venture manufacturing facility in China.

Of course, Versarien isn’t the only materials firm hoping to make money from graphene. It faces tough competition from rivals. Not all of this information is public — many larger companies wouldn’t bother announcing early-stage trials like these.

What are the shares worth?

The commercial potential for graphene could be massive and Versarien could do well. But shareholders need to consider the financial picture as well.

It could be several years before the company achieves commercial success from graphene. In the meantime, it will need cash to support its operations. Some of this will come from existing operations.

The group’s revenue rose by 167% to £4.37m during the first half of this year. Broker forecasts suggest that full-year revenue will rise by 28% to £7.6m for 2017/18 and by 47% to £11.2m in 2018/19.

Unfortunately, this progress won’t generate much profit. Brokers expect a loss of 0.3p per share this year and earnings of 0.6p per share next year. So profits will probably still be a long way short of what’s needed to justify the current share price of 76p.

Although the firm raised £2.8m of fresh cash by selling new shares in November, the interim results show a cash outflow of £1.1m during the period. This suggests to me that the company could run out of cash again in a year or so, given the planned investment in production facilities.

Why I’d sell

The firm’s current market cap of £113m is more than 10 times next year’s forecast sales. That’s a very steep valuation for a company that’s still running at a loss.

By comparison, Morgan Advanced Materials, a profitable rival, trades at less than one times sales.

I believe Versarien’s sky-high valuation leaves shareholders exposed to a lot of downside risk. Even if Versarien is successful, the shares could fall a long way from current levels before they find support.

5G is here – and shares of this ‘sleeping giant’ could be a great way for you to potentially profit!

According to one leading industry firm, the 5G boom could create a global industry worth US $12.3 TRILLION out of thin air…

And if you click here, we’ll show you something that could be key to unlocking 5G’s full potential...

It’s just ONE innovation from a little-known US company that has quietly spent years preparing for this exact moment…

But you need to get in before the crowd catches onto this ‘sleeping giant’.

Click here to learn more.

Roland Head has no position in any of the shares mentioned. The Motley Fool UK has recommended Morgan Advanced Materials. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

Our 6 'Best Buys Now' Shares

The renowned analyst team at The Motley Fool UK have named 6 shares that they believe UK investors should consider buying NOW.

So if you’re looking for more stock ideas to try and best position your portfolio today, then it might be a good day for you. Because we're offering a full 33% off your first year of membership to our flagship share-tipping service, backed by our 'no quibbles' 30-day subscription fee refund guarantee.

Simply enter your email address below to discover how you can take advantage of this.

I would like to receive emails from you about product information and offers from The Fool and its business partners. Each of these emails will provide a link to unsubscribe from future emails. More information about how The Fool collects, stores, and handles personal data is available in its Privacy Statement.